SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Pacira BioSciences, Inc. (PCRX) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Lawsuit Allegations - A shareholder class action lawsuit has been filed against Pacira BioSciences, Inc alleging that the company created a false impression regarding the sufficiency of patent protections on Exparel, impacting its marketing, production, and sales [1] - The lawsuit claims that Pacira was aware that the '495 patent was not as protective as publicly stated by the company [1] Legal Action Details - Shareholders who purchased Pacira shares between August 2, 2023, and August 8, 2024, and suffered significant losses are encouraged to contact Corey D Holzer, Esq for legal rights discussion [2] - The deadline to request the court to be appointed lead plaintiff in the case is March 14, 2025 [3] Law Firm Information - Holzer & Holzer, LLC, a top-rated securities litigation law firm, specializes in representing shareholders and investors in litigation, including class action and derivative cases [3] - Since its founding in 2000, the firm has recovered hundreds of millions of dollars for shareholders affected by fraud and corporate misconduct [3]